skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: HEAL-Link subscriptions: Lippincott Williams & Wilkins remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

LYNCH, Thomas J ; BONDARENKO, Igor ; RECK, Martin ; LUFT, Alexander ; SERWATOWSKI, Piotr ; BARLESI, Fabrice ; CHACKO, Raju ; SEBASTIAN, Martin ; NEAL, Joel ; HAOLAN LU ; CUILLEROT, Jean-Marie

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2046-2054 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

SEQUIST, Lecia V ; YANG, James Chih-Hsin ; SU, Wu-Chou ; BENNOUNA, Jaafar ; KATO, Terufumi ; GORBUNOVA, Vera ; KI HYEONG LEE ; SHAH, Riyaz ; MASSEY, Dan ; ZAZULINA, Victoria ; SHAHIDI, Mehdi ; SCHULER, Martin ; YAMAMOTO, Nobuyuki ; O'BYRNE, Kenneth ; HIRSH, Vera ; MOK, Tony ; GEATER, Sarayut Lucien ; ORLOV, Sergey ; TSAI, Chun-Ming ; BOYER, Michael

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

SOCINSKI, Mark A ; BONDARENKO, Igor ; IGLESIAS, Jose L ; RENSCHLER, Markus F ; KARASEVA, Nina A ; MAKHSON, Anatoly M ; VYNNYCHENKO, Igor ; OKAMOTO, Isamu ; HON, Jeremy K ; HIRSH, Vera ; BHAR, Paul ; HUI ZHANG

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2055-2062 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

VAN CUTSEM, Eric ; TABERNERO, Josep ; MCKENDRICK, Joe ; POLIKOFF, Jonathan ; TELLIER, Alexia ; CASTAN, Rémi ; ALLEGRA, Carmen ; LAKOMY, Radek ; PRENEN, Hans ; PRAUSOVA, Jana ; MACARULLA, Teresa ; RUFF, Paul ; HAZEL, Guy A. Van ; MOISEYENKO, Vladimir ; FERRY, David

Journal of clinical oncology, 2012-10, Vol.30 (28), p.3499-3506 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

JOHNSON, Philip J ; SHUKUI QIN ; LIGONG LU ; CHAO, Yee ; BOUCHER, Eveline ; HAN, Kwang-Hyub ; PAIK, Seung-Woon ; ROBLES-AVINA, Jorge ; KUDO, Masatoshi ; LUNAN YAN ; SOBHONSLIDSUK, Abhasnee ; KOMOV, Dmitry ; PARK, Joong-Won ; DECAENS, Thomas ; TAK, Won-Young ; JENG, Long-Bin ; LIU, David ; EZZEDDINE, Rana ; WALTERS, Ian ; CHENG, Ann-Lii ; POON, Ronnie T. P ; RAOUL, Jean-Luc ; PHILIP, Philip A ; HSU, Chih-Hung ; HU, Tsung-Hui ; HEO, Jeong ; JIANMING XU

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

SPIGEL, David R ; ERVIN, Thomas J ; GOVINDAN, Ramaswamy ; PATEL, Taral ; ORLOV, Sergey V ; WERTHEIM, Michael S ; WEI YU ; JIPING ZHA ; YAUCH, Robert L ; PATEL, Premal H ; PHAN, See-Chun ; PETERSON, Amy C ; RAMLAU, Rodryg A ; DANIEL, Davey B ; GOLDSCHMIDT, Jerome H ; BLUMENSCHEIN, George R ; KRZAKOWSKI, Maciej J ; ROBINET, Gilles ; GODBERT, Benoit ; BARLESI, Fabrice

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4105-4114 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

MOTZER, Robert J ; NOSOV, Dmitry ; KOGAN, Mikhail ; ALEKSEEV, Boris Y ; STERNBERG, Cora N ; SZCZYLIK, Cezary ; CELLA, David ; IVANESCU, Cristina ; KRIVOSHIK, Andrew ; STRAHS, Andrew ; ESTEVES, Brooke ; BERKENBLIT, Anna ; EISEN, Timothy ; HUTSON, Thomas E ; BONDARENKO, Igor ; LESOVOY, Vladimir ; LIPATOV, Oleg ; TOMCZAK, Piotr ; LYULKO, Oleksiy ; ALYASOVA, Anna ; HARZA, Mihai

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3791-3799 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

RECK, Martin ; VON PAWEL, Joachim ; MANEGOLD, Christian ; ZATLOUKAL, Petr ; RAMLAU, Rodryg ; GORBOUNOVA, Vera ; HIRSH, Vera ; LEIGHL, Natasha ; MEZGER, Jörg ; ARCHER, Venice ; MOORE, Nicola

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1227-1234 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

YARDLEY, Denise A ; ISMAIL-KHAN, Roohi R ; MELICHAR, Bohuslav ; LICHINITSER, Mikhail ; MUNSTER, Pamela N ; KLEIN, Pamela M ; CRUICKSHANK, Scott ; MILLER, Kathy D ; LEE, Min J ; TREPEL, Jane B

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2128-2135 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

ROBERT, Nicholas J ; DIERAS, Véronique ; PHAN, See-Chun ; O'SHAUGHNESSY, Joyce ; GLASPY, John ; BRUFSKY, Adam M ; BONDARENKO, Igor ; LIPATOV, Oleg N ; PEREZ, Edith A ; YARDLEY, Denise A ; CHAN, Stephen Y. T ; XIAN ZHOU

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1252-1260 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (94)

Data de Publicação 

De até
Refinar
  1. Antes de1998  (4)
  2. 1998Até2001  (7)
  3. 2002Até2006  (17)
  4. 2007Até2011  (41)
  5. Após 2011  (27)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.